Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Open in API
Filings indexed 636 across all filing types
Latest filing 2021-06-04 AGM Information
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Carens EGM 2021 - Meeting minutes (DUT).pdf
AGM Information Classification · 95% confidence The document text is a notarial record detailing the proceedings of an 'buitengewone algemene vergadering' (Extraordinary General Meeting) of BIOCARTIS GROUP, held on June 4, 2021. The key agenda items discussed and resolved concern the 'Hernieuwing van het toegestane kapitaal' (Renewal of the authorized capital) and 'Statutenwijzigingen' (Statute amendments), specifically modifying Article 10 regarding authorized capital and the board's power to increase capital. This type of meeting, which deals with fundamental corporate governance changes like capital structure and statutory amendments, is typically documented in minutes or resolutions related to a General Meeting. Since the document explicitly details the resolutions passed during a general meeting, it aligns best with the category for AGM-related materials, even though it is an Extraordinary General Meeting (EGM) and not the Annual General Meeting (AGM) itself. Given the options, AGM-R (AGM Information) is the closest fit for formal shareholder meeting documentation, especially when dealing with capital structure changes that often require shareholder approval.
2021-06-04 Dutch
Carens EGM 2021 - Attendance Form (DUT ENG) (draft).pdf
AGM Information Classification · 98% confidence The document is titled "DEELNEMINGSFORMULIER VOOR HOUDERS VAN EFFECTEN" / "ATTENDANCE FORM FOR SECURITIES HOLDERS" and explicitly relates to an "Extraordinary shareholders' meeting" (Buitengewone algemene aandeelhoudersvergadering) scheduled for June 4, 2021. This form is used by shareholders to register their intent to attend or vote at a general meeting. This directly corresponds to the purpose of materials distributed in preparation for an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). Since the definition for AGM-R covers "Presentations and materials shared during the Annual General Meeting (AGM)", and this is a key preparatory document for such a meeting, AGM-R is the most appropriate classification, as it relates to the governance event itself, rather than a specific voting result (DVA) or a proxy solicitation document (PSI), although it is closely related to the mechanics of attendance/voting.
2021-05-17 Dutch
AGM EGM 2021 - Board Report 7199 BCCA (DUT) (final)_SIGNED.pdf
Capital/Financing Update Classification · 98% confidence The document is titled "BIJZONDER VERSLAG VAN DE RAAD VAN BESTUUR OVEREENKOMSTIG ARTIKEL 7:199 VAN HET WETBOEK VAN VENNOOTSCHAPPEN EN VERENIGINGEN" (Special Report of the Board of Directors pursuant to Article 7:199 of the Companies and Associations Code). It explicitly discusses a proposal to renew the authorization for the Board of Directors to increase the company's capital within the limits of the authorized capital ('toegestane kapitaal'). This type of document, which details a proposal for capital structure changes and seeks shareholder approval (to be presented at an EGM), falls under the category of Capital/Financing Update (CAP). Although it is a formal report, its core subject is the authorization for capital changes, making CAP more specific than a general regulatory filing (RNS) or a general governance report (CGR). It is not a full Annual Report (10-K) or an Interim Report (IR).
2021-05-17 Dutch
AGM EGM 2021 - Subdelegation (DUT) (draft).pdf
AGM Information Classification · 99% confidence The document explicitly discusses the appointment of a proxy holder ('Plaatsvervanging') for the Ordinary and Extraordinary General Shareholders' Meetings ('gewone en buitengewone algemene aandeelhoudersvergaderingen') scheduled for May 14, 2021. The agenda items cover standard AGM topics like approving annual accounts, discharging directors, remuneration policy, and capital authorization renewals. This material is directly related to the preparation for and administration of the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). The document length (2954 chars) is not a factor suggesting an RPA, as this is the core material, not just an announcement of the meeting.
2021-05-17 Dutch
Carens EGM 2021 - Vote by mail (DUT ENG) (draft).pdf
AGM Information Classification · 98% confidence The document is titled "FORMULIER VOOR STEMMING PER BRIEF VOTE BY MAIL FORM" for an "Extraordinary shareholders' meeting" (Buitengewone algemene aandeelhoudersvergadering). It explicitly details the process for shareholders to cast their votes by mail regarding agenda items, including the renewal of authorization for the Board of Directors to increase capital. This form is a mechanism for shareholders to exercise their voting rights ahead of a general meeting. This aligns directly with the definition of materials related to shareholder voting and meeting procedures, which is covered by the Proxy Solicitation & Information Statement (PSI) category, as it solicits a vote via mail, or potentially Declaration of Voting Results & Voting Rights Announcements (DVA) if it were the results, but since it is the mechanism *to* vote, PSI is more appropriate, or potentially AGM-R if it were the main AGM materials. Given the focus on the 'Vote by Mail Form' for an Extraordinary General Meeting, it is a proxy/voting solicitation document. However, since the document is a form for shareholders to *cast* their vote (proxy/ballot), it strongly relates to the process leading up to a vote, which is best captured by PSI (Proxy Solicitation & Information Statement). If the meeting was the Annual General Meeting, AGM-R might apply, but for an Extraordinary meeting focused on voting mechanics, PSI is the most precise fit among the options related to shareholder meetings and voting.
2021-05-17 Dutch
Carens EGM 2021 - Convening Notice (DUT) (draft).pdf
AGM Information Classification · 99% confidence The document is explicitly titled "OPROEPING" (Call/Summons) for a "BUITENGEWONE ALGEMENE AANDEELHOUDERSVERGADERING" (Extraordinary General Shareholders' Meeting). It details the agenda, proposals for resolutions (like renewing capital authorization and amending bylaws), quorum requirements, and procedures for participation and voting for this specific meeting scheduled for June 4, 2021. This content directly corresponds to the materials distributed to shareholders in preparation for a general meeting, which falls under the scope of AGM Information (AGM-R) or Proxy Solicitation & Information Statement (PSI). Since it is a formal summons and agenda for an Extraordinary General Meeting, AGM-R is the most precise fit, as it covers presentations and materials shared during General Meetings. It is not a DEF 14A (Remuneration) or a DVA (Declaration of Voting Results), as it precedes the meeting.
2021-05-17 Dutch

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.